TG Therapeutics, Inc. (TGTX) Stock

Healthcare · Biotechnology · Member of Other US Stocks

TG Therapeutics, Inc. (TGTX) closed at USD 54.37 on 2026-10-14, a change of +57.4 % over the past year, with a market capitalization of USD 8.57B.

TG Therapeutics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

TG Therapeutics, Inc. key figures

Previous close

USD 54.37 (2026-10-14)

1-year change

+57.4 %

Market cap

USD 8.57B

Enterprise value

USD 8.15B

P/E ratio (trailing)

19.79

P/E ratio (forward)

20.68

EPS (trailing)

2.83

EPS (forward)

2.71

PEG ratio

1.61

Price to book

13.15

Revenue growth

70.3 %

Earnings growth

-70.6 %

Dividend per share (trailing)

0.00

Short ratio

16.50

Employees

399

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About TG Therapeutics, Inc.

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Jiangsu Hengrui Medicine Co. The company was incorporated in 1993 and is based in Morrisville, North Carolina.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for TG Therapeutics, Inc. and compare it with other stocks.